ENTRADA THERAPEUTICS, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$25M
R&D
$142M
D&A
$4M
Operating Income
$-158M
EBITDA
$-154M
Tax Provision
$924K
Net Income
$-144M
Operating Margin
-621.1%
Net Margin
-565.5%
Deferred Tax Liabilities
$566K
DTA Valuation Allowance
$108M
Tax Credit Carryforwards
$14M
NOL Carryforwards
$50M
ETR (Continuing Operations)
-0.6%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
6.8%
Operating Lease Cost
$15M
Revenue YoY Variation
-87.9%
Income YoY Variation
-435.9%